ZEP Information

ZEP(Zhejiang Eazy Pharmchem Co., Ltd.) mainly engages in the import and export of pharmaceutical intermediates and APls, with independent R&D of new crystalline APls of non-infringement synthetic routes and pharmaceutical intermediates as its core. ZEP has continuously increased its investment in independent R&D. In 2015,we established a professional R&D team fornew crystalline APls on non-infringement synthetic routes inthe patent period. We constantly develop non-infringingprocesses by studying impurities, stability, method of analysisand Process Validation at the kilogram Level, along withexclusive licensing of patents or sub-contract production withfactories having supported the production of first generics. All these efforts aim at supporting our customers in theirchallenging of primary drug and production of first generics. Our R&D team has applied for a number of internationalpatents, some of which have been authorized and convertedinto commercial products, which has successfully contributed to the ANDA application of many customers. The business team keep on improving their service, and provides added value to customers with highly cohesive teamwork and highly specialized services. We have independent QA department to perform pre-audit, supporting regulations and registration. lt offers valuable references for customers to select high-quality suppliers atearly stage, provide professional corrections to suppliers about their quality and file management system. Meanwhile, in order to enhance the professional capabilities, we provide regular training about regulations and quality systems for our employees. With constant efforts in all aspects in recent years, our company has gained rapid development which shows in rises in sales, nearly 500 million yuan in 2021. Now we has formed a market layout mainly in Korea, Japan,India and Europe, supplemented by Egypt,Pakistan and South America, and continues to penetrate into other markets.